SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/80C978407010F30780EA995C7F34857B82CA6B40C886020C99C5B5FA670E2752C8D5648F0363CA67985EE125EF110B22>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/80C978407010F30780EA995C7F34857B82CA6B40C886020C99C5B5FA670E2752C8D5648F0363CA67985EE125EF110B22
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/80C978407010F30780EA995C7F34857B82CA6B40C886020C99C5B5FA670E2752C8D5648F0363CA67985EE125EF110B22
http://www.w3.org/2000/01/rdf-schema#comment
"Results demonstrate that NR2F6 promotes the stem cell-like phenotype and induces cisplatin resistance in epithelial ovarian cancer (EOC) cells by activating the Notch3 pathway."
xsd:string
http://purl.uniprot.org/uniprot/#_6230433950E4C1214C58928414A0D0779A25F2DCDE834D785070AB286B21D348603D9077AA08801BC8089CFB8BA0081F
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/80C978407010F30780EA995C7F34857B82CA6B40C886020C99C5B5FA670E2752C8D5648F0363CA67985EE125EF110B22
http://purl.uniprot.org/uniprot/P10588
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/80C978407010F30780EA995C7F34857B82CA6B40C886020C99C5B5FA670E2752C8D5648F0363CA67985EE125EF110B22
http://purl.uniprot.org/uniprot/#_P10588-mappedCitation-30895619
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/80C978407010F30780EA995C7F34857B82CA6B40C886020C99C5B5FA670E2752C8D5648F0363CA67985EE125EF110B22